This AI-generated translation is currently being refined.
This medication is indicated for adults for the treatment of spasmodic intestinal pain.
Medicine
Trimebutine 100 mg Viatris Conseil, box of 20 tablets
1 box of 20 tablets
3,95€
In stockThis is a medicine. Information on precautions for use (drug interactions, contraindications, special warnings, adverse reactions...) and dosage are detailed in the summary of product characteristics.
In accordance with current regulations, any suspected adverse effect of a medication must be reported: Een bijwerking melden. .
FOR ADULTS ONLY. Read the package insert carefully before use.
The usual dosage is 1 100-mg tablet 3 times a day, which may be increased in exceptional cases to up to two 100-mg tablets 3 times a day.
The recommended duration of use is 3 days. In the absence of any warning signs, the maximum duration of use is 7 days.
Contraindications:
- Hypersensitivity to the active ingredient or to any of the excipients.
- Although this medication is intended for adults only, please note that trimebutine is contraindicated in children under 2 years of age.
- Hypersensitivity or intolerance to gluten, due to the presence of wheat starch (gluten).
Pregnancy:
Animal studies have not shown any teratogenic effects.
There are currently no sufficiently relevant data to assess whether trimebutine may cause birth defects or have a teratogenic effect when administered during pregnancy.
Consequently, as a precautionary measure, it is best not to use trimebutine during the first trimester of pregnancy. Since no adverse effects are expected for the mother or the child, the use of trimebutine during the second and third trimesters of pregnancy should be considered only if necessary.
Breastfeeding:
It is not known whether trimebutine passes into breast milk. As a precaution, it is best to avoid using trimebutine while breastfeeding.
The usual dosage is 1 100-mg tablet 3 times a day, which may be increased in exceptional cases to up to two 100-mg tablets 3 times a day.
The recommended duration of use is 3 days. In the absence of any warning signs, the maximum duration of use is 7 days.
Contraindications:
- Hypersensitivity to the active ingredient or to any of the excipients.
- Although this medication is intended for adults only, please note that trimebutine is contraindicated in children under 2 years of age.
- Hypersensitivity or intolerance to gluten, due to the presence of wheat starch (gluten).
Pregnancy:
Animal studies have not shown any teratogenic effects.
There are currently no sufficiently relevant data to assess whether trimebutine may cause birth defects or have a teratogenic effect when administered during pregnancy.
Consequently, as a precautionary measure, it is best not to use trimebutine during the first trimester of pregnancy. Since no adverse effects are expected for the mother or the child, the use of trimebutine during the second and third trimesters of pregnancy should be considered only if necessary.
Breastfeeding:
It is not known whether trimebutine passes into breast milk. As a precaution, it is best to avoid using trimebutine while breastfeeding.
Maléate de trimébutine 100 mg, pour un comprimé.
Excipients à effet notoire : lactose, saccharose, amidon de blé. Pour la liste complète des excipients, voir la notice.
Excipients à effet notoire : lactose, saccharose, amidon de blé. Pour la liste complète des excipients, voir la notice.
Log in 
